|4Apr 6, 7:47 PM ET

McGrath Lynne Fahey 4

4 · Alzamend Neuro, Inc. · Filed Apr 6, 2022

Insider Transaction Report

Form 4
Period: 2022-03-28
Transactions
  • Sale

    Common Stock

    2022-03-28$1.21/sh+25,000$30,32575,000 total
Footnotes (1)
  • [F1]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    marketforms-55974.xmlPrimary

    PRIMARY DOCUMENT